Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

Background Critical examination of the quality and validity of available allergic rhinitis (AR)
literature is necessary to improve understanding and to appropriately translate this …

Allergen immunotherapy is effective in patients with IgE-dependent allergic rhinitis and
asthma. When immunotherapy is given continuously for 3 years, there is persistent clinical …

Background Allergen immunotherapy (AIT) is an effective treatment for allergic
rhinoconjunctivitis (AR) with or without asthma. It is important to note that due to the complex …

Abstract Background The European Academy of Allergy and Clinical Immunology (EAACI) is
in the process of developing Guidelines on Allergen Immunotherapy (AIT) for Allergic …

We have prepared this document,“Sublingual Immunotherapy: World Allergy Organization
Position Paper 2013 Update”, according to the evidence-based criteria, revising and …

Background Allergen immunotherapy (AIT) has been thoroughly documented in randomized
controlled trials (RCT s). It is the only immune‐modifying and causal treatment available for …

Allergen-specific immunotherapy has been used for 100 years as a desensitizing therapy for
allergic diseases and represents the potentially curative and specific method of treatment …

Allergen-specific immunotherapy (allergen-SIT) is a potentially curative treatment approach
in allergic diseases. It has been used for almost 100 years as a desensitizing therapy. The …

BACKGROUND: Allergic rhinoconjunctivitis is an increasingly common source of morbidity,
with sensitivity to cats accounting for 10% to 15% of disease burden. Allergy to cats is also a …